Campaign Accomplishments
Accomplishments for current campaign coming soon! In the meantime, check out some accomplishments from our last campaign:
Over 8,500 emails and calls to Congressional offices.
Over 100 lobbying visits in Washington D.C. and across the country.
At least 20 editorials published by students and allies across the country:
View Biologics Campaign in a larger map
Format: Author (University), “Article,” Publisher, Date
- Laura Musselwhite (Duke University School of Medicine) and Jane Andrews (Johns Hopkins University School of Medicine), “Protect Pharmaceutical Innovation,” Science, 6/10/2010
- Anthony So and Samuel Katz (Duke University), “Biologics Boondoggle,” New York Times, 3/7/2010
- Marce Abare (University of Michigan School of Medicine), “Health care bills grant billions to Big Pharma, prevent generic competition,” The Portland Press Herald, 2/26/2010
- Govind Randgrass (University of Michigan School of Medicine), “A Monopoly on Biologics will Drain Health Care Resources,” The Lancet Student Blog, 12/2009
- Jim Curry (University of Iowa), “Correspondence Interview: Anthony So, MD, MPA,” Global Pulse, 12/2009
- Govind Randgrass (University of Michigan School of Medicine), “Bill would give 12-year monopoly to Big Pharma,” Kalamazoo Gazette, 12/12/2009
- Jim Curry (University of Iowa), “Pharmacy lobby limits access to lifesaving drugs,” Des Moines Register, 12/11/2009
- Christina Benkert (John Hopkins University School of Public Health), “Change health bill to save big on drugs,” Lansing State Journal, 12/6/2009
- Christina Benkert (John Hopkins University School of Public Health), “Generics law for new class of drugs is needed in health care reform,” Saginaw Paper, 12/2/2009
- Alexander Tsai and Nicholas Rosenlicht (University of California at San Francisco), “Eshoo needs to close loophole in biologics legislation,” San Jose Mercury News, 12/1/2009
- Jessica de Jarnette (Medical College of Georgia), “Monopoly on Expensive, Life-Saving Drugs Unfair,” Atlanta Journal Constitution, 11/17/2009
- Laura Musselwhite (Duke University School of Medicine), “Trick or Treat for Affordable Biologics,” The Lancet Student, 11/9/2009
- Eric Butter (University of North Carolina School of Public Health), “Make it easy to create these generic drugs,” Charlotte Observer, 11/5/2009
- Derek Lundberg (University of North Carolina at Chapel Hill), “Billions at stake ‘biologic’ medicines,” Daily Tar Heel, 11/5/2009
- Laura Musselwhite (Duke University School of Medicine), “Bring down drug prices by lifting barriers to generics,” The Winston-Salem Journal, 10/24/2009
- Taylor Gilliland and Katie Fitzpatrick (University of California at San Diego), “The ins and outs of healthcare reform,” San Diego Union Tribune, 10/18/2009
- Laura Musselwhite (Duke University School of Medicine), “A cost-cutter that’s missing in health bills,” The Raleigh-Durham News and Observer, 10/7/2009
- Jane Andrews (Johns Hopkins University School of Medicine), “Drug Competition in Peril: Legislation Would Stymie Generic Versions Of Expensive Biologic Medications,” Baltimore Sun, 8/28/2009
- Jane Andrews (Johns Hopkins University School of Medicine), “Drug Competition in Peril: Legislation Would Stymie Generic Versions Of Expensive Biologic Medications,” Chicago Tribune, 8/28/2009
Sarah Rimmington (Essential Action), “Don’t hand Big Pharma a windfall,” The Roanoke Times, 6/12/2009
Great debate with Ana Eshoo (D-CA) in the Huffington Post:
Jane Hamsher’s first post
Jane Hamsher’s second post
Eshoo responds to Hamsher
UCSF doctors respond to Eshoo
Healthcare Reform: “Trick” or “Treat”?
Around Halloween, the AffordableMedsNow.org campaign hosted lobbying events at four Congressional offices around the country plus many Congressional offices in Washington D.C. to ask Congress whether it would “Trick” patients with a fake biologics bill or “Treat” them with a bill that enabled affordable generic biologic drugs now.
Caroling for Global Access
On World AIDS Day this December, students in Ann Arbor, M.I., sang Christmas carols to Rep. John Dingell (D-MI) with a biologics twist, generating press in The Michigan Daily and Ann Arbor News:
Cut the Sweetheart Deal
For Valentine’s Day, we asked Congress to stop giving Pharma a sweetheart deal:
